Clinical Trials Browser

Phase 4 × Withdrawn × gadolinium ethoxybenzyl DTPA × Clear all

NCT03215355 2021-01-27

Improving CBCT for Liver IG-SBRT Using Gadoxetate Disodium

Phase 4 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms